CompletedInterventionalPhase 3Last updated Sep 19, 2024

BCG Vaccination to Protect Healthcare Workers Against COVID-19

BCG Vaccination to Reduce the Impact of COVID-19 in Healthcare Workers (BRACE) Trial

Overview

ClinicalTrials.gov ID: NCT04327206
Lead Sponsor: Murdoch Childrens Research InstituteOTHER
Brief Summary: Phase III, two-group multicentre, randomised controlled trial in up to 10 078 healthcare workers to determine if BCG vaccination reduces the incidence and severity of COVID-19 during the 2020 pandemic.
Study Type: Interventional

Secondary IDs

U1111-1256-4104Registry Identifier

The Universal Trial Number (UTN)

INV-017302Other Grant/Funding Number

BILL & MELINDA GATES foundation

Status

Study Record Dates

NCT04348370Completed

BCG Vaccine for Health Care Workers as Defense Against COVID 19

NCT04379336Completed

BCG Vaccination for Healthcare Workers in COVID-19 Pandemic

NCT04461379Unknown status

Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers

NCT04384549Unknown status

Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers

NCT04373291Completed

Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic

NCT04659941Unknown status

Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers